These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37610311)

  • 1. Challenges in anti-aging medicine-trends in biomarker discovery and therapeutic interventions for a healthy lifespan.
    Popescu I; Deelen J; Illario M; Adams J
    J Cell Mol Med; 2023 Sep; 27(18):2643-2650. PubMed ID: 37610311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
    Wong PF; Dharmani M; Ramasamy TS
    Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skin aging-cellular senescence : What is the future?].
    Scharffetter-Kochanek K; Wang Y; Makrantonaki E; Crisan D; Wlaschek M; Geiger H; Maity P
    Dermatologie (Heidelb); 2023 Sep; 74(9):645-656. PubMed ID: 37638987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senotherapeutic Drugs: A New Avenue for Skincare?
    Lee BP; Harries LW
    Plast Reconstr Surg; 2021 Dec; 148(6S):21S-26S. PubMed ID: 34847094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The costs and benefits of senotherapeutics for human health.
    Raffaele M; Vinciguerra M
    Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cellular senescence based on interorganelle communication, multilevel proteostasis, and metabolic control.
    Cavinato M; Madreiter-Sokolowski CT; Büttner S; Schosserer M; Zwerschke W; Wedel S; Grillari J; Graier WF; Jansen-Dürr P
    FEBS J; 2021 Jun; 288(12):3834-3854. PubMed ID: 33200494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From genoprotection to rejuvenation.
    Tabibzadeh S
    Front Biosci (Landmark Ed); 2021 Jan; 26(1):97-162. PubMed ID: 33049666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senotherapeutics: emerging strategy for healthy aging and age-related disease.
    Kim EC; Kim JR
    BMB Rep; 2019 Jan; 52(1):47-55. PubMed ID: 30526770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging use of senolytics and senomorphics against aging and chronic diseases.
    Martel J; Ojcius DM; Wu CY; Peng HH; Voisin L; Perfettini JL; Ko YF; Young JD
    Med Res Rev; 2020 Nov; 40(6):2114-2131. PubMed ID: 32578904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs that target aging: how do we discover them?
    Myers A; Lithgow GJ
    Expert Opin Drug Discov; 2019 Jun; 14(6):541-548. PubMed ID: 30973028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-targeted senotherapeutic interventions.
    Atayik MC; Çakatay U
    Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular senescence and senolytics: the path to the clinic.
    Chaib S; Tchkonia T; Kirkland JL
    Nat Med; 2022 Aug; 28(8):1556-1568. PubMed ID: 35953721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the discovery of senolytics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    Mech Ageing Dev; 2021 Dec; 200():111587. PubMed ID: 34656616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms.
    Tchkonia T; Palmer AK; Kirkland JL
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1481-e1487. PubMed ID: 33155651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bright and dark side of skin senescence. Could skin rejuvenation anti-senescence interventions become a "bright" new strategy for the prevention of age-related skin pathologies?
    Georgakopoulou EA; Valsamidi C; Veroutis D; Havaki S
    Mech Ageing Dev; 2021 Jan; 193():111409. PubMed ID: 33249190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
    Basisty N; Kale A; Patel S; Campisi J; Schilling B
    Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to Slow Aging in Humans: Are We Ready?
    Longo VD; Antebi A; Bartke A; Barzilai N; Brown-Borg HM; Caruso C; Curiel TJ; de Cabo R; Franceschi C; Gems D; Ingram DK; Johnson TE; Kennedy BK; Kenyon C; Klein S; Kopchick JJ; Lepperdinger G; Madeo F; Mirisola MG; Mitchell JR; Passarino G; Rudolph KL; Sedivy JM; Shadel GS; Sinclair DA; Spindler SR; Suh Y; Vijg J; Vinciguerra M; Fontana L
    Aging Cell; 2015 Aug; 14(4):497-510. PubMed ID: 25902704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.